glp-1 treatment for pre-diabetes Diabetes Patients Also Struggle to Access Agonists GLP-1 Medications for Weight Loss

Molecular Properties Property Value Systematic Name Aib-His-D-2-Nal-D-Phe-Lys-NH Molecular Formula CHNO Molecular Weight 711.85 Da CAS Number 170851-70-4 Structure Class Synthetic pentapeptide Receptor Target GHS-R1a (growth hormone secretagogue receptor type 1a) Development Novo Nordisk (NNC 26-0161) The sequence includes -aminoisobutyric acid (Aib) at position 1, D-2-naphthylalanine (D-2-Nal) at position 3, and D-phenylalanine (D-Phe) at position 4

Greff D, Juhsz AE, Vncsa S, Vradi A, Sipos Z, Szinte J, et al

FTC Lawsuit Against PBMs Moves Forward : A federal judge rejected an attempt to block the FTCs lawsuit against major PBMs, including Caremark, Express Scripts, and Optum Rx

Dulaglutide (Trulicity) A weekly injection approved in 2014, at 0.75 mg to 4.5 mg, with cardiovascular-outcomes data

2,22 Metabolic Disorders Insulin resistance affects 5070% of women with PCOS

Vitamin B12 deserves special attention